Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106b-5p APC 1.71 0 -0.24 0.1992 miRNAWalker2 validate; miRTarBase -0.14 0.00091 23087084 miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells
2 hsa-miR-107 APC 0.9 5.0E-5 -0.24 0.1992 miRanda -0.16 0.00649 NA
3 hsa-miR-320b APC 1.11 0.0005 -0.24 0.1992 miRanda -0.16 9.0E-5 NA
4 hsa-miR-20a-3p APC2 1.14 0.00045 -1.51 0.00013 mirMAP -0.27 0.0021 NA
5 hsa-miR-221-5p APC2 1.89 0 -1.51 0.00013 mirMAP -0.34 4.0E-5 NA
6 hsa-miR-345-5p APC2 1.84 0 -1.51 0.00013 mirMAP -0.29 0.00069 NA
7 hsa-miR-625-5p APC2 0.54 0.2038 -1.51 0.00013 mirMAP -0.31 0 NA
8 hsa-miR-205-5p AXIN2 3.14 0.02932 -0.66 0.25177 miRNATAP -0.17 0 NA
9 hsa-miR-34c-5p AXIN2 2.21 0.00038 -0.66 0.25177 miRanda -0.21 0.00103 NA
10 hsa-miR-944 AXIN2 3.33 0.01778 -0.66 0.25177 MirTarget; PITA; miRNATAP -0.2 0 NA
11 hsa-miR-103a-3p BTRC 0.84 0 -0.39 0.00796 MirTarget; miRNATAP -0.19 0.00257 NA
12 hsa-miR-148b-5p BTRC 1.04 0.00196 -0.39 0.00796 mirMAP -0.11 0.0005 NA
13 hsa-miR-15a-5p BTRC 1.04 0 -0.39 0.00796 miRNAWalker2 validate; MirTarget; miRNATAP -0.19 0.00011 NA
14 hsa-miR-15b-5p BTRC 1.62 0 -0.39 0.00796 MirTarget; miRNATAP -0.11 0.00209 NA
15 hsa-miR-16-1-3p BTRC 1.43 0 -0.39 0.00796 mirMAP -0.1 0.00835 NA
16 hsa-miR-16-5p BTRC 1.01 1.0E-5 -0.39 0.00796 miRNAWalker2 validate; MirTarget; miRNATAP -0.15 0.00163 NA
17 hsa-miR-320a BTRC 0.59 0.0119 -0.39 0.00796 miRNAWalker2 validate; PITA -0.16 0.00028 NA
18 hsa-miR-320b BTRC 1.11 0.0005 -0.39 0.00796 PITA -0.11 0.00036 NA
19 hsa-miR-454-3p BTRC 0.63 0.01349 -0.39 0.00796 mirMAP -0.19 0 NA
20 hsa-miR-505-3p BTRC 0.83 0.00112 -0.39 0.00796 MirTarget -0.12 0.00372 NA
21 hsa-miR-195-3p CACYBP -1.35 2.0E-5 0.91 0 mirMAP -0.2 0 NA
22 hsa-miR-30a-3p CACYBP -1.73 0 0.91 0 MirTarget -0.16 2.0E-5 NA
23 hsa-miR-130b-5p CAMK2A 0.7 0.05101 -0.13 0.82753 mirMAP -0.37 0.00178 NA
24 hsa-miR-142-5p CAMK2A 1.56 1.0E-5 -0.13 0.82753 PITA; miRNATAP -0.46 0.00015 NA
25 hsa-miR-144-3p CAMK2A -0.13 0.79825 -0.13 0.82753 mirMAP -0.3 0.00022 NA
26 hsa-miR-148a-3p CAMK2A -1.54 4.0E-5 -0.13 0.82753 miRNATAP -0.32 0.00397 NA
27 hsa-miR-148b-5p CAMK2A 1.04 0.00196 -0.13 0.82753 mirMAP -0.38 0.00256 NA
28 hsa-miR-15b-3p CAMK2A 1.76 0 -0.13 0.82753 mirMAP -0.51 9.0E-5 NA
29 hsa-miR-19b-1-5p CAMK2A 1.39 0 -0.13 0.82753 mirMAP -0.61 2.0E-5 NA
30 hsa-miR-25-3p CAMK2A 1.01 0.00042 -0.13 0.82753 MirTarget -0.53 0.00031 NA
31 hsa-miR-26a-5p CAMK2A -0.38 0.04425 -0.13 0.82753 miRNATAP -0.94 3.0E-5 NA
32 hsa-miR-26b-5p CAMK2A -0.3 0.16008 -0.13 0.82753 miRNATAP -1.07 0 NA
33 hsa-miR-30b-5p CAMK2A -0.43 0.05936 -0.13 0.82753 mirMAP -0.87 0 NA
34 hsa-miR-30d-5p CAMK2A -0.55 0.01401 -0.13 0.82753 mirMAP -0.95 0 NA
35 hsa-miR-30e-5p CAMK2A -0.57 0.01125 -0.13 0.82753 mirMAP -0.64 0.0008 NA
36 hsa-miR-32-5p CAMK2A 0.42 0.10646 -0.13 0.82753 MirTarget -0.95 0 NA
37 hsa-miR-320c CAMK2A 0.46 0.24061 -0.13 0.82753 mirMAP -0.54 2.0E-5 NA
38 hsa-miR-335-5p CAMK2A 1.6 6.0E-5 -0.13 0.82753 mirMAP -0.61 0 NA
39 hsa-miR-338-3p CAMK2A -0.96 0.01915 -0.13 0.82753 miRNATAP -0.3 0.00432 NA
40 hsa-miR-361-3p CAMK2A -0.13 0.56605 -0.13 0.82753 mirMAP -0.64 0.00126 NA
41 hsa-miR-3614-5p CAMK2A 1.1 0.00706 -0.13 0.82753 mirMAP -0.43 3.0E-5 NA
42 hsa-miR-363-3p CAMK2A -1.17 0.01565 -0.13 0.82753 MirTarget -0.29 0.0011 NA
43 hsa-miR-429 CAMK2A 1.4 0.009 -0.13 0.82753 miRNATAP -0.27 0.0005 NA
44 hsa-miR-616-5p CAMK2A 0.83 0.03478 -0.13 0.82753 mirMAP -0.32 0.00341 NA
45 hsa-miR-625-5p CAMK2A 0.54 0.2038 -0.13 0.82753 mirMAP -0.51 0 NA
46 hsa-miR-7-1-3p CAMK2A 0.71 0.04123 -0.13 0.82753 MirTarget -0.6 0 NA
47 hsa-miR-92a-3p CAMK2A 1.22 1.0E-5 -0.13 0.82753 MirTarget -0.69 1.0E-5 NA
48 hsa-miR-29a-3p CAMK2B -0.11 0.61501 -2.37 0.00126 mirMAP -0.76 0.00147 NA
49 hsa-miR-625-5p CAMK2B 0.54 0.2038 -2.37 0.00126 mirMAP -0.64 0 NA
50 hsa-miR-197-3p CAMK2D 0.89 0.0002 -0.67 0.00279 miRNATAP -0.18 0.00721 NA
51 hsa-miR-421 CAMK2D 1.81 0 -0.67 0.00279 miRNATAP -0.15 0.00111 NA
52 hsa-miR-127-5p CAMK2G 0.68 0.02163 -0.26 0.15921 MirTarget; PITA; miRNATAP -0.14 0.0014 NA
53 hsa-miR-16-2-3p CAMK2G 1.8 0 -0.26 0.15921 mirMAP -0.15 0.00029 NA
54 hsa-miR-16-5p CAMK2G 1.01 1.0E-5 -0.26 0.15921 miRNAWalker2 validate -0.18 0.00182 NA
55 hsa-miR-1976 CAMK2G 0.92 0.00012 -0.26 0.15921 MirTarget -0.18 0.00078 NA
56 hsa-miR-484 CAMK2G 0.71 0.00234 -0.26 0.15921 mirMAP -0.16 0.00418 NA
57 hsa-miR-590-3p CAMK2G 1.12 0.00016 -0.26 0.15921 miRanda -0.17 0.00013 NA
58 hsa-miR-338-3p CCND1 -0.96 0.01915 0.62 0.1312 miRNAWalker2 validate; miRTarBase; miRanda -0.24 0.00086 NA
59 hsa-let-7a-3p CCND2 0.5 0.04111 -0.5 0.3 mirMAP -0.54 0.0001 20418948 MicroRNA let 7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2
60 hsa-let-7b-3p CCND2 0.22 0.29604 -0.5 0.3 mirMAP -0.46 0.00588 NA
61 hsa-miR-106b-5p CCND2 1.71 0 -0.5 0.3 miRNAWalker2 validate; miRTarBase; miRNATAP -0.42 9.0E-5 NA
62 hsa-miR-130b-5p CCND2 0.7 0.05101 -0.5 0.3 mirMAP -0.39 2.0E-5 NA
63 hsa-miR-141-3p CCND2 1.46 0.00116 -0.5 0.3 MirTarget; TargetScan -0.21 0.00436 NA
64 hsa-miR-15b-5p CCND2 1.62 0 -0.5 0.3 miRNATAP -0.44 0.00021 NA
65 hsa-miR-16-2-3p CCND2 1.8 0 -0.5 0.3 mirMAP -0.55 0 NA
66 hsa-miR-16-5p CCND2 1.01 1.0E-5 -0.5 0.3 miRNAWalker2 validate; miRNATAP -0.67 1.0E-5 NA
67 hsa-miR-181a-2-3p CCND2 0.9 0.00083 -0.5 0.3 mirMAP -0.38 0.00236 NA
68 hsa-miR-182-5p CCND2 0.89 0.03106 -0.5 0.3 miRNAWalker2 validate; miRTarBase; miRNATAP -0.32 9.0E-5 NA
69 hsa-miR-183-5p CCND2 1.66 0.00052 -0.5 0.3 miRNATAP -0.29 2.0E-5 NA
70 hsa-miR-19b-3p CCND2 0.76 0.00653 -0.5 0.3 miRNAWalker2 validate; MirTarget; miRNATAP -0.32 0.00853 NA
71 hsa-miR-21-3p CCND2 1.75 0 -0.5 0.3 mirMAP -0.33 0.0051 NA
72 hsa-miR-224-3p CCND2 1.52 0.0065 -0.5 0.3 mirMAP -0.27 4.0E-5 NA
73 hsa-miR-26b-5p CCND2 -0.3 0.16008 -0.5 0.3 mirMAP; miRNATAP -0.58 0.00034 NA
74 hsa-miR-301a-3p CCND2 1.45 1.0E-5 -0.5 0.3 miRNAWalker2 validate -0.38 0.0002 NA
75 hsa-miR-3065-3p CCND2 -1.04 0.02184 -0.5 0.3 MirTarget; miRNATAP -0.2 0.00685 NA
76 hsa-miR-3065-5p CCND2 -0.24 0.63312 -0.5 0.3 mirMAP -0.24 0.00057 NA
77 hsa-miR-424-5p CCND2 1.09 0.00042 -0.5 0.3 miRNATAP -0.39 0.0003 NA
78 hsa-miR-429 CCND2 1.4 0.009 -0.5 0.3 miRNATAP -0.19 0.002 NA
79 hsa-miR-450b-5p CCND2 0.46 0.13274 -0.5 0.3 MirTarget; PITA; miRNATAP -0.32 0.00413 NA
80 hsa-miR-590-3p CCND2 1.12 0.00016 -0.5 0.3 miRanda; mirMAP -0.33 0.00348 NA
81 hsa-miR-590-5p CCND2 1.04 0.00027 -0.5 0.3 mirMAP -0.41 0.00055 NA
82 hsa-miR-9-3p CCND2 0.33 0.54111 -0.5 0.3 MirTarget; mirMAP; miRNATAP -0.19 0.00361 NA
83 hsa-miR-93-5p CCND2 1.75 0 -0.5 0.3 miRNATAP -0.32 0.00244 NA
84 hsa-miR-96-5p CCND2 1.14 0.00943 -0.5 0.3 TargetScan; miRNATAP -0.33 3.0E-5 NA
85 hsa-miR-96-5p CCND3 1.14 0.00943 0.04 0.88352 TargetScan -0.12 0.00328 NA
86 hsa-miR-140-5p CHD8 0.21 0.303 0.08 0.52589 miRanda -0.16 0.0007 NA
87 hsa-miR-221-3p CHD8 1.33 0 0.08 0.52589 MirTarget; miRNATAP -0.11 0.00136 NA
88 hsa-miR-222-3p CHD8 1.39 0 0.08 0.52589 MirTarget; miRNATAP -0.11 0.00087 NA
89 hsa-miR-186-5p CREBBP 0.15 0.43471 -0.11 0.45436 mirMAP; miRNATAP -0.14 0.00768 NA
90 hsa-miR-107 CSNK1A1 0.9 5.0E-5 -0.13 0.51313 PITA; miRanda; miRNATAP -0.29 0 NA
91 hsa-miR-126-5p CSNK1A1 0.42 0.07532 -0.13 0.51313 mirMAP -0.16 0.00576 NA
92 hsa-miR-148a-5p CSNK1A1 -0.69 0.0793 -0.13 0.51313 MirTarget -0.16 0 NA
93 hsa-miR-186-5p CSNK1A1 0.15 0.43471 -0.13 0.51313 miRNAWalker2 validate; miRNATAP -0.27 0.00019 NA
94 hsa-miR-19a-3p CSNK1A1 1.27 0.00011 -0.13 0.51313 mirMAP -0.11 0.00763 NA
95 hsa-miR-2110 CSNK1A1 0.76 0.0724 -0.13 0.51313 miRNATAP -0.14 1.0E-5 NA
96 hsa-miR-29a-5p CSNK1A1 0.59 0.02301 -0.13 0.51313 mirMAP -0.15 0.00587 NA
97 hsa-miR-30a-5p CSNK1A1 -1.72 0 -0.13 0.51313 MirTarget; miRNATAP -0.11 0.00528 NA
98 hsa-miR-30b-5p CSNK1A1 -0.43 0.05936 -0.13 0.51313 MirTarget; mirMAP; miRNATAP -0.25 2.0E-5 NA
99 hsa-miR-30c-5p CSNK1A1 -0.98 5.0E-5 -0.13 0.51313 MirTarget; mirMAP; miRNATAP -0.18 0.00097 NA
100 hsa-miR-30d-5p CSNK1A1 -0.55 0.01401 -0.13 0.51313 MirTarget; miRNATAP -0.25 3.0E-5 NA
101 hsa-miR-320a CSNK1A1 0.59 0.0119 -0.13 0.51313 mirMAP -0.17 0.00251 NA
102 hsa-miR-320b CSNK1A1 1.11 0.0005 -0.13 0.51313 mirMAP -0.15 0.00043 NA
103 hsa-miR-335-3p CSNK1A1 2.52 0 -0.13 0.51313 mirMAP -0.16 0 NA
104 hsa-miR-501-3p CSNK1A1 0.73 0.02704 -0.13 0.51313 TargetScan; miRNATAP -0.16 0.00012 NA
105 hsa-miR-502-3p CSNK1A1 -0.16 0.55747 -0.13 0.51313 miRNATAP -0.23 0 NA
106 hsa-miR-577 CSNK1A1 0.91 0.22561 -0.13 0.51313 mirMAP -0.1 0 NA
107 hsa-miR-592 CSNK1A1 0.78 0.2045 -0.13 0.51313 MirTarget; PITA; miRNATAP -0.14 0 NA
108 hsa-miR-652-3p CSNK1A1 1.03 0.00034 -0.13 0.51313 miRNAWalker2 validate -0.17 0.00038 NA
109 hsa-miR-664a-5p CSNK1A1 -0.13 0.62435 -0.13 0.51313 MirTarget -0.22 1.0E-5 NA
110 hsa-miR-7-1-3p CSNK1A1 0.71 0.04123 -0.13 0.51313 mirMAP -0.26 0 NA
111 hsa-miR-30a-3p CSNK1E -1.73 0 0.53 0.0008 miRNATAP -0.11 0.00091 NA
112 hsa-miR-30c-5p CSNK1E -0.98 5.0E-5 0.53 0.0008 miRNAWalker2 validate -0.18 0.0001 NA
113 hsa-miR-30d-3p CSNK1E -0.55 0.04337 0.53 0.0008 miRNATAP -0.14 0.00107 NA
114 hsa-miR-125b-5p CSNK2A1 -0.51 0.13327 0.37 0.01132 MirTarget; miRNATAP -0.14 0 NA
115 hsa-miR-143-3p CSNK2A1 -0.66 0.04832 0.37 0.01132 MirTarget -0.13 3.0E-5 NA
116 hsa-miR-126-5p CSNK2A2 0.42 0.07532 -0.24 0.1246 mirMAP -0.14 0.00403 NA
117 hsa-miR-181c-5p CSNK2A2 0.34 0.11293 -0.24 0.1246 mirMAP -0.21 0.00011 NA
118 hsa-miR-186-5p CSNK2A2 0.15 0.43471 -0.24 0.1246 mirMAP -0.22 0.00028 NA
119 hsa-miR-30d-3p CSNK2A2 -0.55 0.04337 -0.24 0.1246 mirMAP -0.13 0.0026 NA
120 hsa-miR-32-5p CSNK2A2 0.42 0.10646 -0.24 0.1246 mirMAP -0.12 0.00502 NA
121 hsa-miR-320a CSNK2A2 0.59 0.0119 -0.24 0.1246 mirMAP -0.13 0.00787 NA
122 hsa-miR-342-3p CTBP2 0.32 0.26915 -0.01 0.94438 MirTarget; PITA; miRanda; miRNATAP -0.29 0 NA
123 hsa-miR-10a-5p CTNNBIP1 -0.47 0.1488 -0.33 0.26613 miRNATAP -0.32 0 NA
124 hsa-miR-192-5p CTNNBIP1 0.08 0.94106 -0.33 0.26613 miRNAWalker2 validate; MirTarget; miRNATAP -0.14 0 NA
125 hsa-miR-215-5p CTNNBIP1 0.72 0.57378 -0.33 0.26613 miRNAWalker2 validate; MirTarget -0.11 0 NA
126 hsa-miR-29b-3p CTNNBIP1 -0.23 0.36746 -0.33 0.26613 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.27 0.0013 NA
127 hsa-miR-3614-5p CTNNBIP1 1.1 0.00706 -0.33 0.26613 miRNATAP -0.18 0.00047 NA
128 hsa-miR-625-5p CTNNBIP1 0.54 0.2038 -0.33 0.26613 mirMAP -0.26 0 NA
129 hsa-miR-21-5p CXXC4 1.75 0 -0.1 0.88463 mirMAP -0.67 0.00542 NA
130 hsa-miR-708-3p CXXC4 0.62 0.27536 -0.1 0.88463 MirTarget -0.25 0.00187 NA
131 hsa-miR-944 CXXC4 3.33 0.01778 -0.1 0.88463 MirTarget; mirMAP -0.14 0.00037 NA
132 hsa-let-7f-1-3p DAAM1 1.29 0 -0.57 0.03626 MirTarget -0.29 5.0E-5 NA
133 hsa-let-7g-3p DAAM1 0.65 0.01031 -0.57 0.03626 MirTarget -0.4 0 NA
134 hsa-miR-130b-3p DAAM1 1.33 5.0E-5 -0.57 0.03626 MirTarget; miRNATAP -0.24 4.0E-5 NA
135 hsa-miR-130b-5p DAAM1 0.7 0.05101 -0.57 0.03626 MirTarget -0.19 0.00035 NA
136 hsa-miR-140-5p DAAM1 0.21 0.303 -0.57 0.03626 miRanda -0.44 1.0E-5 NA
137 hsa-miR-142-3p DAAM1 1.32 0.00015 -0.57 0.03626 miRanda -0.2 0.00019 NA
138 hsa-miR-181a-5p DAAM1 1.39 0 -0.57 0.03626 mirMAP -0.32 6.0E-5 NA
139 hsa-miR-181b-5p DAAM1 1.64 0 -0.57 0.03626 mirMAP -0.27 2.0E-5 NA
140 hsa-miR-186-5p DAAM1 0.15 0.43471 -0.57 0.03626 MirTarget; mirMAP -0.49 0 NA
141 hsa-miR-194-5p DAAM1 -0.13 0.90607 -0.57 0.03626 miRNATAP -0.11 0 NA
142 hsa-miR-19a-3p DAAM1 1.27 0.00011 -0.57 0.03626 miRNATAP -0.25 1.0E-5 NA
143 hsa-miR-19b-3p DAAM1 0.76 0.00653 -0.57 0.03626 miRNATAP -0.31 1.0E-5 NA
144 hsa-miR-29b-3p DAAM1 -0.23 0.36746 -0.57 0.03626 MirTarget; miRNATAP -0.24 0.00212 NA
145 hsa-miR-301b-3p DAAM1 1.1 0.07156 -0.57 0.03626 MirTarget -0.12 0.00555 NA
146 hsa-miR-32-3p DAAM1 0.58 0.11837 -0.57 0.03626 mirMAP -0.28 0 NA
147 hsa-miR-32-5p DAAM1 0.42 0.10646 -0.57 0.03626 miRNATAP -0.38 0 NA
148 hsa-miR-320a DAAM1 0.59 0.0119 -0.57 0.03626 miRanda -0.31 0.00018 NA
149 hsa-miR-320b DAAM1 1.11 0.0005 -0.57 0.03626 miRanda -0.32 0 NA
150 hsa-miR-320c DAAM1 0.46 0.24061 -0.57 0.03626 miRanda -0.18 0.00149 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 72 351 1.073e-99 4.992e-96
2 CANONICAL WNT SIGNALING PATHWAY 36 95 3.701e-58 8.61e-55
3 REGULATION OF WNT SIGNALING PATHWAY 45 310 4.144e-52 6.428e-49
4 NON CANONICAL WNT SIGNALING PATHWAY 34 140 3.945e-47 4.589e-44
5 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 32 236 1.476e-35 1.373e-32
6 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 29 197 2.885e-33 2.237e-30
7 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 48 1021 2.993e-32 1.99e-29
8 POSITIVE REGULATION OF RESPONSE TO STIMULUS 60 1929 1.836e-31 1.068e-28
9 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 56 1672 1.279e-30 6.61e-28
10 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 17 39 7.978e-29 3.712e-26
11 POSITIVE REGULATION OF GENE EXPRESSION 54 1733 8.708e-28 3.684e-25
12 REGULATION OF CELL DIFFERENTIATION 50 1492 7.229e-27 2.587e-24
13 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 50 1492 7.229e-27 2.587e-24
14 TISSUE DEVELOPMENT 50 1518 1.595e-26 5.302e-24
15 EPITHELIUM DEVELOPMENT 41 945 8.089e-26 2.509e-23
16 POSITIVE REGULATION OF CELL COMMUNICATION 49 1532 2.363e-25 6.873e-23
17 REGULATION OF PROTEIN MODIFICATION PROCESS 51 1710 3.972e-25 1.087e-22
18 REGULATION OF ORGAN MORPHOGENESIS 25 242 1.015e-24 2.623e-22
19 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 22 162 1.752e-24 4.291e-22
20 TISSUE MORPHOGENESIS 32 533 3.3e-24 7.197e-22
21 MORPHOGENESIS OF AN EPITHELIUM 29 400 3.212e-24 7.197e-22
22 TUBE MORPHOGENESIS 27 323 3.403e-24 7.197e-22
23 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 51 1805 4.75e-24 9.61e-22
24 NEGATIVE REGULATION OF CELL COMMUNICATION 43 1192 5.62e-24 1.089e-21
25 TUBE DEVELOPMENT 32 552 9.695e-24 1.804e-21
26 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 45 1360 1.181e-23 2.113e-21
27 REGULATION OF PHOSPHORUS METABOLIC PROCESS 47 1618 2.012e-22 3.468e-20
28 ORGAN MORPHOGENESIS 36 841 2.606e-22 4.331e-20
29 INTRACELLULAR SIGNAL TRANSDUCTION 46 1572 5.067e-22 8.13e-20
30 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 40 1142 1.03e-21 1.597e-19
31 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 18 110 1.092e-21 1.64e-19
32 POSITIVE REGULATION OF MOLECULAR FUNCTION 48 1791 1.82e-21 2.646e-19
33 PATTERN SPECIFICATION PROCESS 27 418 3.117e-21 4.395e-19
34 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 39 1135 7.663e-21 1.049e-18
35 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 47 1784 1.178e-20 1.565e-18
36 POSITIVE REGULATION OF CELL DIFFERENTIATION 34 823 1.526e-20 1.973e-18
37 EMBRYO DEVELOPMENT 35 894 2.056e-20 2.585e-18
38 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 29 554 2.876e-20 3.521e-18
39 CARDIOVASCULAR SYSTEM DEVELOPMENT 33 788 4.198e-20 4.884e-18
40 CIRCULATORY SYSTEM DEVELOPMENT 33 788 4.198e-20 4.884e-18
41 NEURON DIFFERENTIATION 34 874 1.001e-19 1.136e-17
42 EMBRYONIC MORPHOGENESIS 28 539 1.756e-19 1.945e-17
43 REGIONALIZATION 23 311 1.875e-19 2.029e-17
44 NEUROGENESIS 41 1402 2.082e-19 2.202e-17
45 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 36 1036 2.553e-19 2.583e-17
46 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 36 1036 2.553e-19 2.583e-17
47 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 35 1004 8.31e-19 8.227e-17
48 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 337 1.133e-18 1.098e-16
49 REGULATION OF CELL CYCLE 34 949 1.283e-18 1.218e-16
50 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 40 1395 1.341e-18 1.248e-16
51 REGULATION OF EMBRYONIC DEVELOPMENT 16 114 2.93e-18 2.673e-16
52 REGULATION OF CELLULAR PROTEIN LOCALIZATION 27 552 3.975e-18 3.557e-16
53 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 23 365 6.67e-18 5.856e-16
54 REGULATION OF BINDING 21 283 7.616e-18 6.563e-16
55 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 36 1152 7.845e-18 6.637e-16
56 REGULATION OF CELL DEATH 40 1472 8.829e-18 7.336e-16
57 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 42 1656 1.209e-17 9.87e-16
58 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 17 152 1.28e-17 1.027e-15
59 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 10 22 1.348e-17 1.063e-15
60 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 33 957 1.457e-17 1.13e-15
61 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 44 1848 1.599e-17 1.22e-15
62 CELL FATE COMMITMENT 19 227 3.413e-17 2.561e-15
63 ANTERIOR POSTERIOR PATTERN SPECIFICATION 18 194 3.926e-17 2.899e-15
64 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 30 801 6.377e-17 4.636e-15
65 REGULATION OF PROTEIN LOCALIZATION 32 950 9.918e-17 7.099e-15
66 REGULATION OF CELL PROLIFERATION 39 1496 1.068e-16 7.526e-15
67 REGULATION OF CELLULAR RESPONSE TO STRESS 28 691 1.137e-16 7.778e-15
68 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 21 323 1.127e-16 7.778e-15
69 NEURAL TUBE DEVELOPMENT 16 149 2.368e-16 1.597e-14
70 REGULATION OF RESPONSE TO STRESS 38 1468 3.812e-16 2.534e-14
71 SENSORY ORGAN DEVELOPMENT 24 493 4.16e-16 2.727e-14
72 REGULATION OF CELL MORPHOGENESIS 25 552 4.976e-16 3.216e-14
73 CELL PROLIFERATION 27 672 5.425e-16 3.458e-14
74 PROTEIN PHOSPHORYLATION 31 944 6.749e-16 4.195e-14
75 DORSAL VENTRAL AXIS SPECIFICATION 9 20 6.761e-16 4.195e-14
76 CELL DEVELOPMENT 37 1426 9.857e-16 6.035e-14
77 CELLULAR RESPONSE TO RETINOIC ACID 12 65 1.823e-15 1.101e-13
78 REGULATION OF KINASE ACTIVITY 28 776 2.17e-15 1.294e-13
79 FC EPSILON RECEPTOR SIGNALING PATHWAY 15 142 2.764e-15 1.628e-13
80 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 21 381 3.094e-15 1.799e-13
81 REGULATION OF TRANSFERASE ACTIVITY 30 946 5.57e-15 3.2e-13
82 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 17 220 6.761e-15 3.837e-13
83 POSITIVE REGULATION OF CATALYTIC ACTIVITY 37 1518 7.113e-15 3.988e-13
84 REGULATION OF PROTEIN TARGETING 19 307 9.052e-15 5.014e-13
85 CELL ACTIVATION 24 568 9.677e-15 5.236e-13
86 REGULATION OF CELLULAR LOCALIZATION 34 1277 9.603e-15 5.236e-13
87 REGULATION OF CELL DEVELOPMENT 28 836 1.401e-14 7.495e-13
88 HEART DEVELOPMENT 22 466 1.533e-14 8.107e-13
89 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 22 470 1.826e-14 9.545e-13
90 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 2.005e-14 1.037e-12
91 REGULATION OF CYTOPLASMIC TRANSPORT 22 481 2.926e-14 1.496e-12
92 POSITIVE REGULATION OF CELL DEATH 24 605 3.857e-14 1.951e-12
93 SOMITOGENESIS 11 62 4.547e-14 2.275e-12
94 SEGMENTATION 12 89 9.6e-14 4.752e-12
95 AXIS SPECIFICATION 12 90 1.103e-13 5.4e-12
96 REGULATION OF PROTEIN IMPORT 15 183 1.225e-13 5.939e-12
97 DORSAL VENTRAL PATTERN FORMATION 12 91 1.264e-13 6.064e-12
98 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 13 119 1.396e-13 6.628e-12
99 CELL CYCLE 33 1316 1.434e-13 6.738e-12
100 NEGATIVE REGULATION OF MOLECULAR FUNCTION 30 1079 1.745e-13 8.117e-12
101 CELL CYCLE PROCESS 30 1081 1.83e-13 8.431e-12
102 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 40 1977 1.903e-13 8.595e-12
103 NEURAL TUBE FORMATION 12 94 1.887e-13 8.595e-12
104 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 35 1517 2.424e-13 1.084e-11
105 REGULATION OF TRANSPORT 38 1804 2.782e-13 1.233e-11
106 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 26 799 2.836e-13 1.245e-11
107 REGULATION OF JNK CASCADE 14 159 3.14e-13 1.366e-11
108 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 197 3.622e-13 1.561e-11
109 NEGATIVE REGULATION OF CELL DIFFERENTIATION 23 609 3.937e-13 1.681e-11
110 RESPONSE TO OXYGEN CONTAINING COMPOUND 33 1381 5.481e-13 2.319e-11
111 REGULATION OF CELL CYCLE PROCESS 22 558 5.831e-13 2.444e-11
112 REGULATION OF INTRACELLULAR TRANSPORT 23 621 5.897e-13 2.45e-11
113 SOMITE DEVELOPMENT 11 78 6.455e-13 2.658e-11
114 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 13 134 6.589e-13 2.689e-11
115 REGULATION OF PROTEIN BINDING 14 168 6.725e-13 2.721e-11
116 FC RECEPTOR SIGNALING PATHWAY 15 206 6.958e-13 2.791e-11
117 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 28 983 7.466e-13 2.969e-11
118 REGULATION OF PROTEIN CATABOLIC PROCESS 19 393 7.59e-13 2.993e-11
119 PHOSPHORYLATION 31 1228 8.038e-13 3.143e-11
120 MITOTIC CELL CYCLE 25 766 8.255e-13 3.201e-11
121 NEGATIVE REGULATION OF GENE EXPRESSION 34 1493 8.579e-13 3.299e-11
122 RESPONSE TO RETINOIC ACID 12 107 9.214e-13 3.514e-11
123 CELLULAR RESPONSE TO LIPID 20 457 1.116e-12 4.223e-11
124 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 16 258 1.342e-12 5.034e-11
125 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 15 218 1.585e-12 5.899e-11
126 REGULATION OF STEM CELL DIFFERENTIATION 12 113 1.786e-12 6.596e-11
127 BETA CATENIN TCF COMPLEX ASSEMBLY 9 43 2.038e-12 7.466e-11
128 REGULATION OF MAPK CASCADE 23 660 2.063e-12 7.501e-11
129 DOPAMINERGIC NEURON DIFFERENTIATION 8 28 2.284e-12 8.24e-11
130 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 24 740 2.915e-12 1.043e-10
131 RESPONSE TO LIPID 26 888 3.127e-12 1.111e-10
132 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 12 121 4.074e-12 1.436e-10
133 GASTRULATION 13 155 4.311e-12 1.508e-10
134 REGULATION OF IMMUNE SYSTEM PROCESS 32 1403 4.709e-12 1.635e-10
135 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 16 282 5.194e-12 1.79e-10
136 POSITIVE REGULATION OF CELL CYCLE 17 332 5.491e-12 1.879e-10
137 CELL DEATH 27 1001 7.377e-12 2.505e-10
138 TUBE FORMATION 12 129 8.772e-12 2.958e-10
139 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 20 513 9.165e-12 3.068e-10
140 REGULATION OF PROTEOLYSIS 23 711 9.373e-12 3.115e-10
141 REGULATION OF ORGANELLE ORGANIZATION 29 1178 9.718e-12 3.207e-10
142 REGULATION OF IMMUNE RESPONSE 25 858 9.807e-12 3.214e-10
143 RHYTHMIC PROCESS 16 298 1.194e-11 3.887e-10
144 EMBRYONIC ORGAN DEVELOPMENT 18 406 1.363e-11 4.405e-10
145 REGULATION OF CATABOLIC PROCESS 23 731 1.639e-11 5.261e-10
146 VASCULATURE DEVELOPMENT 19 469 1.662e-11 5.296e-10
147 POSITIVE REGULATION OF CELL DEVELOPMENT 19 472 1.855e-11 5.871e-10
148 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 17 360 1.976e-11 6.213e-10
149 CELLULAR RESPONSE TO ACID CHEMICAL 13 175 2.021e-11 6.31e-10
150 RESPONSE TO GROWTH FACTOR 19 475 2.068e-11 6.416e-10
151 POSITIVE REGULATION OF CELL PROLIFERATION 24 814 2.143e-11 6.605e-10
152 POSITIVE REGULATION OF KINASE ACTIVITY 19 482 2.66e-11 8.142e-10
153 REGULATION OF JUN KINASE ACTIVITY 10 81 2.968e-11 9.026e-10
154 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 17 370 3.039e-11 9.182e-10
155 REGULATION OF HYDROLASE ACTIVITY 30 1327 3.259e-11 9.659e-10
156 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 12 144 3.239e-11 9.659e-10
157 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 21 616 3.225e-11 9.659e-10
158 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 14 228 4.247e-11 1.251e-09
159 PEPTIDYL SERINE MODIFICATION 12 148 4.474e-11 1.309e-09
160 REGULATION OF CELLULAR COMPONENT MOVEMENT 23 771 4.758e-11 1.384e-09
161 REGULATION OF GROWTH 21 633 5.34e-11 1.543e-09
162 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 117 5.996e-11 1.722e-09
163 HEAD DEVELOPMENT 22 709 6.309e-11 1.79e-09
164 DEVELOPMENTAL GROWTH 16 333 6.275e-11 1.79e-09
165 SENSORY ORGAN MORPHOGENESIS 14 239 7.954e-11 2.236e-09
166 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 19 514 7.976e-11 2.236e-09
167 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 6 14 8.234e-11 2.294e-09
168 MIDBRAIN DEVELOPMENT 10 90 8.664e-11 2.4e-09
169 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 15 289 8.852e-11 2.423e-09
170 NEGATIVE REGULATION OF CELL DEATH 24 872 8.848e-11 2.423e-09
171 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 7 26 9.167e-11 2.494e-09
172 IMMUNE SYSTEM PROCESS 36 1984 1.084e-10 2.932e-09
173 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 1.232e-10 3.313e-09
174 REPRODUCTIVE SYSTEM DEVELOPMENT 17 408 1.393e-10 3.687e-09
175 REGULATION OF MITOTIC CELL CYCLE 18 468 1.395e-10 3.687e-09
176 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 67 1.381e-10 3.687e-09
177 WOUND HEALING 18 470 1.494e-10 3.929e-09
178 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 22 750 1.841e-10 4.786e-09
179 MORPHOGENESIS OF A BRANCHING STRUCTURE 12 167 1.839e-10 4.786e-09
180 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 21 684 2.215e-10 5.725e-09
181 HEART MORPHOGENESIS 13 212 2.231e-10 5.736e-09
182 DIGESTIVE TRACT MORPHOGENESIS 8 48 2.526e-10 6.457e-09
183 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 135 2.842e-10 7.187e-09
184 RESPONSE TO ENDOGENOUS STIMULUS 30 1450 2.828e-10 7.187e-09
185 REGULATION OF MAP KINASE ACTIVITY 15 319 3.51e-10 8.827e-09
186 RESPONSE TO WOUNDING 19 563 3.706e-10 9.272e-09
187 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 12 181 4.673e-10 1.163e-08
188 EYE DEVELOPMENT 15 326 4.739e-10 1.173e-08
189 INOSITOL PHOSPHATE MEDIATED SIGNALING 6 18 4.997e-10 1.23e-08
190 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 23 876 5.841e-10 1.43e-08
191 EMBRYONIC ORGAN MORPHOGENESIS 14 279 6.096e-10 1.485e-08
192 IMMUNE SYSTEM DEVELOPMENT 19 582 6.45e-10 1.563e-08
193 REGULATION OF CELL GROWTH 16 391 6.618e-10 1.595e-08
194 SKELETAL SYSTEM DEVELOPMENT 17 455 7.416e-10 1.779e-08
195 GLAND DEVELOPMENT 16 395 7.669e-10 1.83e-08
196 REGULATION OF OSTEOBLAST DIFFERENTIATION 10 112 7.73e-10 1.835e-08
197 REGULATION OF EPITHELIAL CELL PROLIFERATION 14 285 8.042e-10 1.899e-08
198 MESENCHYME DEVELOPMENT 12 190 8.166e-10 1.909e-08
199 STEM CELL DIFFERENTIATION 12 190 8.166e-10 1.909e-08
200 SINGLE ORGANISM CELL ADHESION 17 459 8.471e-10 1.971e-08
201 CONNECTIVE TISSUE DEVELOPMENT 12 194 1.037e-09 2.4e-08
202 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 16 406 1.141e-09 2.628e-08
203 EMBRYONIC PATTERN SPECIFICATION 8 58 1.224e-09 2.806e-08
204 GROWTH 16 410 1.314e-09 2.997e-08
205 STEM CELL PROLIFERATION 8 60 1.619e-09 3.675e-08
206 CELL CELL SIGNALING 21 767 1.744e-09 3.92e-08
207 REGULATION OF CELLULAR COMPONENT BIOGENESIS 21 767 1.744e-09 3.92e-08
208 POSITIVE REGULATION OF TRANSPORT 23 936 2.088e-09 4.67e-08
209 CELL CYCLE PHASE TRANSITION 13 255 2.147e-09 4.78e-08
210 REGULATION OF CELL ADHESION 19 629 2.327e-09 5.156e-08
211 LOCOMOTION 25 1114 2.349e-09 5.18e-08
212 POSITIVE REGULATION OF JUN KINASE ACTIVITY 8 63 2.417e-09 5.304e-08
213 CENTRAL NERVOUS SYSTEM DEVELOPMENT 22 872 3.059e-09 6.683e-08
214 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 13 263 3.12e-09 6.729e-08
215 APPENDAGE DEVELOPMENT 11 169 3.124e-09 6.729e-08
216 LIMB DEVELOPMENT 11 169 3.124e-09 6.729e-08
217 NEGATIVE REGULATION OF CELL GROWTH 11 170 3.324e-09 7.12e-08
218 NEGATIVE REGULATION OF CELL PROLIFERATION 19 643 3.336e-09 7.12e-08
219 RESPONSE TO ACID CHEMICAL 14 319 3.443e-09 7.315e-08
220 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 18 573 3.501e-09 7.404e-08
221 NEGATIVE REGULATION OF BINDING 10 131 3.603e-09 7.552e-08
222 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 10 131 3.603e-09 7.552e-08
223 PROTEIN COMPLEX SUBUNIT ORGANIZATION 29 1527 4.324e-09 9.023e-08
224 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 13 274 5.11e-09 1.062e-07
225 REGULATION OF OSSIFICATION 11 178 5.391e-09 1.115e-07
226 PEPTIDYL THREONINE MODIFICATION 7 46 6.797e-09 1.399e-07
227 POSITIVE REGULATION OF PROTEIN IMPORT 9 104 7.457e-09 1.529e-07
228 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 18 602 7.548e-09 1.54e-07
229 AXIS ELONGATION 6 27 7.645e-09 1.553e-07
230 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 23 1008 8.471e-09 1.714e-07
231 REGULATION OF FAT CELL DIFFERENTIATION 9 106 8.83e-09 1.763e-07
232 FAT CELL DIFFERENTIATION 9 106 8.83e-09 1.763e-07
233 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 15 404 8.777e-09 1.763e-07
234 POSITIVE REGULATION OF MAPK CASCADE 16 470 9.191e-09 1.828e-07
235 NEGATIVE REGULATION OF GROWTH 12 236 9.522e-09 1.885e-07
236 CONVERGENT EXTENSION 5 14 1.012e-08 1.996e-07
237 POSITIVE REGULATION OF GROWTH 12 238 1.046e-08 2.054e-07
238 RESPONSE TO ABIOTIC STIMULUS 23 1024 1.137e-08 2.223e-07
239 DIGESTIVE SYSTEM DEVELOPMENT 10 148 1.174e-08 2.287e-07
240 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 7 50 1.245e-08 2.414e-07
241 NEGATIVE REGULATION OF PROTEIN BINDING 8 79 1.511e-08 2.917e-07
242 POSITIVE REGULATION OF CELL CYCLE PROCESS 12 247 1.582e-08 3.043e-07
243 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 10 154 1.72e-08 3.294e-07
244 POSITIVE REGULATION OF PROTEOLYSIS 14 363 1.773e-08 3.381e-07
245 MAMMARY GLAND EPITHELIUM DEVELOPMENT 7 53 1.895e-08 3.599e-07
246 RESPONSE TO DRUG 15 431 2.077e-08 3.928e-07
247 MAMMARY GLAND DEVELOPMENT 9 117 2.109e-08 3.973e-07
248 MUSCLE STRUCTURE DEVELOPMENT 15 432 2.142e-08 4.018e-07
249 PARAXIAL MESODERM DEVELOPMENT 5 16 2.189e-08 4.091e-07
250 LEUKOCYTE CELL CELL ADHESION 12 255 2.254e-08 4.195e-07
251 MESODERM DEVELOPMENT 9 118 2.273e-08 4.213e-07
252 SECOND MESSENGER MEDIATED SIGNALING 10 160 2.479e-08 4.577e-07
253 PALATE DEVELOPMENT 8 85 2.71e-08 4.983e-07
254 EMBRYONIC AXIS SPECIFICATION 6 33 2.783e-08 5.098e-07
255 EPITHELIAL TO MESENCHYMAL TRANSITION 7 56 2.812e-08 5.13e-07
256 CELLULAR COMPONENT MORPHOGENESIS 21 900 2.854e-08 5.187e-07
257 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 6 34 3.364e-08 6.043e-07
258 REGULATION OF CELL CYCLE PHASE TRANSITION 13 321 3.352e-08 6.043e-07
259 BRAIN MORPHOGENESIS 6 34 3.364e-08 6.043e-07
260 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 23 1087 3.429e-08 6.136e-07
261 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 10 166 3.52e-08 6.275e-07
262 RESPONSE TO ORGANIC CYCLIC COMPOUND 21 917 3.93e-08 6.98e-07
263 CALCIUM MEDIATED SIGNALING 8 90 4.263e-08 7.514e-07
264 POST ANAL TAIL MORPHOGENESIS 5 18 4.255e-08 7.514e-07
265 REPRODUCTION 25 1297 4.84e-08 8.498e-07
266 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 9 129 4.947e-08 8.653e-07
267 EMBRYONIC DIGIT MORPHOGENESIS 7 61 5.168e-08 9.006e-07
268 REGULATION OF CELL SUBSTRATE ADHESION 10 173 5.207e-08 9.04e-07
269 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 5 19 5.749e-08 9.944e-07
270 BIOLOGICAL ADHESION 22 1032 6.294e-08 1.085e-06
271 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 16 541 6.495e-08 1.107e-06
272 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 16 541 6.495e-08 1.107e-06
273 REGULATION OF MUSCLE ADAPTATION 7 63 6.493e-08 1.107e-06
274 MESENCHYME MORPHOGENESIS 6 38 6.779e-08 1.151e-06
275 LYMPHOCYTE ACTIVATION 13 342 7.03e-08 1.189e-06
276 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 20 867 7.716e-08 1.301e-06
277 MACROMOLECULAR COMPLEX DISASSEMBLY 10 182 8.399e-08 1.411e-06
278 REGULATION OF DEVELOPMENTAL GROWTH 12 289 8.902e-08 1.49e-06
279 MESODERM MORPHOGENESIS 7 66 9.013e-08 1.498e-06
280 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 9.013e-08 1.498e-06
281 LEUKOCYTE ACTIVATION 14 414 9.083e-08 1.504e-06
282 RESPONSE TO CYTOKINE 18 714 1.012e-07 1.669e-06
283 REGULATION OF CELL JUNCTION ASSEMBLY 7 68 1.112e-07 1.828e-06
284 REGULATION OF CIRCADIAN RHYTHM 8 103 1.231e-07 2.002e-06
285 CELLULAR RESPONSE TO STRESS 27 1565 1.226e-07 2.002e-06
286 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 8 103 1.231e-07 2.002e-06
287 SOMATIC STEM CELL DIVISION 5 22 1.285e-07 2.08e-06
288 UROGENITAL SYSTEM DEVELOPMENT 12 299 1.288e-07 2.08e-06
289 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 1.327e-07 2.137e-06
290 NEURAL PRECURSOR CELL PROLIFERATION 7 70 1.362e-07 2.185e-06
291 PROTEIN AUTOPHOSPHORYLATION 10 192 1.387e-07 2.217e-06
292 BLOOD VESSEL MORPHOGENESIS 13 364 1.446e-07 2.305e-06
293 NEGATIVE REGULATION OF CELL DEVELOPMENT 12 303 1.486e-07 2.361e-06
294 CARTILAGE DEVELOPMENT 9 147 1.526e-07 2.416e-06
295 POSITIVE REGULATION OF HYDROLASE ACTIVITY 20 905 1.543e-07 2.426e-06
296 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 8 106 1.539e-07 2.426e-06
297 NEGATIVE REGULATION OF CELL CYCLE 14 433 1.573e-07 2.464e-06
298 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 9 148 1.618e-07 2.526e-06
299 IN UTERO EMBRYONIC DEVELOPMENT 12 311 1.969e-07 3.063e-06
300 FORMATION OF PRIMARY GERM LAYER 8 110 2.052e-07 3.183e-06
301 SKELETAL SYSTEM MORPHOGENESIS 10 201 2.124e-07 3.284e-06
302 REGULATION OF CELLULAR RESPONSE TO HEAT 7 76 2.415e-07 3.721e-06
303 POSITIVE REGULATION OF MAP KINASE ACTIVITY 10 207 2.79e-07 4.285e-06
304 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 262 2.828e-07 4.328e-06
305 CELLULAR RESPONSE TO ABIOTIC STIMULUS 11 263 2.937e-07 4.481e-06
306 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 11 3.092e-07 4.702e-06
307 CELL CELL ADHESION 16 608 3.157e-07 4.786e-06
308 POSITIVE REGULATION OF CATABOLIC PROCESS 13 395 3.682e-07 5.562e-06
309 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 14 465 3.729e-07 5.615e-06
310 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 16 616 3.759e-07 5.643e-06
311 PROTEASOMAL PROTEIN CATABOLIC PROCESS 11 271 3.958e-07 5.922e-06
312 NEURON PROJECTION DEVELOPMENT 15 545 4.343e-07 6.477e-06
313 REGULATION OF PROTEIN STABILITY 10 221 5.099e-07 7.579e-06
314 REGULATION OF NEURON DIFFERENTIATION 15 554 5.341e-07 7.914e-06
315 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 171 5.513e-07 8.144e-06
316 STEM CELL DIVISION 5 29 5.613e-07 8.265e-06
317 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 8 126 5.838e-07 8.57e-06
318 HEMATOPOIETIC STEM CELL PROLIFERATION 4 13 6.641e-07 9.627e-06
319 REGULATION OF STEM CELL PROLIFERATION 7 88 6.634e-07 9.627e-06
320 REGULATION OF CELL FATE SPECIFICATION 4 13 6.641e-07 9.627e-06
321 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 4 13 6.641e-07 9.627e-06
322 OUTFLOW TRACT MORPHOGENESIS 6 56 7.341e-07 1.061e-05
323 NEGATIVE REGULATION OF PHOSPHORYLATION 13 422 7.761e-07 1.118e-05
324 FOREBRAIN DEVELOPMENT 12 357 8.538e-07 1.225e-05
325 ANGIOGENESIS 11 293 8.556e-07 1.225e-05
326 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 18 829 9.006e-07 1.282e-05
327 INNER EAR MORPHOGENESIS 7 92 8.987e-07 1.282e-05
328 MESENCHYMAL CELL DIFFERENTIATION 8 134 9.331e-07 1.324e-05
329 RESPONSE TO ALCOHOL 12 362 9.88e-07 1.397e-05
330 REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 363 1.017e-06 1.434e-05
331 EYE MORPHOGENESIS 8 136 1.044e-06 1.468e-05
332 PEPTIDYL AMINO ACID MODIFICATION 18 841 1.106e-06 1.548e-05
333 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 95 1.118e-06 1.548e-05
334 CHONDROCYTE DIFFERENTIATION 6 60 1.111e-06 1.548e-05
335 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 95 1.118e-06 1.548e-05
336 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 6 60 1.111e-06 1.548e-05
337 CELL CYCLE G2 M PHASE TRANSITION 8 138 1.166e-06 1.61e-05
338 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 303 1.188e-06 1.636e-05
339 REGULATION OF MESODERM DEVELOPMENT 4 15 1.257e-06 1.72e-05
340 CELLULAR COMPONENT DISASSEMBLY 14 515 1.257e-06 1.72e-05
341 PROTEIN COMPLEX BIOGENESIS 21 1132 1.282e-06 1.739e-05
342 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 1.286e-06 1.739e-05
343 PROTEIN DESTABILIZATION 5 34 1.286e-06 1.739e-05
344 PROTEIN COMPLEX ASSEMBLY 21 1132 1.282e-06 1.739e-05
345 REGULATION OF SMOOTHENED SIGNALING PATHWAY 6 62 1.352e-06 1.818e-05
346 EMBRYONIC HEART TUBE MORPHOGENESIS 6 62 1.352e-06 1.818e-05
347 PLATELET ACTIVATION 8 142 1.447e-06 1.94e-05
348 POSITIVE REGULATION OF CELL ADHESION 12 376 1.469e-06 1.964e-05
349 REGULATION OF EPIDERMIS DEVELOPMENT 6 63 1.488e-06 1.984e-05
350 RESPONSE TO NITROGEN COMPOUND 18 859 1.496e-06 1.989e-05
351 NEGATIVE REGULATION OF KINASE ACTIVITY 10 250 1.564e-06 2.074e-05
352 NEURON DEVELOPMENT 16 687 1.579e-06 2.087e-05
353 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 8 144 1.608e-06 2.119e-05
354 CAMERA TYPE EYE MORPHOGENESIS 7 101 1.692e-06 2.224e-05
355 RESPIRATORY SYSTEM DEVELOPMENT 9 197 1.795e-06 2.353e-05
356 REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 103 1.931e-06 2.517e-05
357 REGULATION OF MUSCLE ORGAN DEVELOPMENT 7 103 1.931e-06 2.517e-05
358 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 9 199 1.952e-06 2.536e-05
359 SOMATIC STEM CELL POPULATION MAINTENANCE 6 66 1.962e-06 2.543e-05
360 POSITIVE REGULATION OF CELL GROWTH 8 148 1.976e-06 2.554e-05
361 CELL DIVISION 13 460 2.023e-06 2.607e-05
362 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 17 2.172e-06 2.769e-05
363 REGULATION OF CHROMATIN BINDING 4 17 2.172e-06 2.769e-05
364 ESTABLISHMENT OF TISSUE POLARITY 4 17 2.172e-06 2.769e-05
365 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 2.172e-06 2.769e-05
366 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 22 1275 2.275e-06 2.892e-05
367 RESPONSE TO HORMONE 18 893 2.587e-06 3.28e-05
368 NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 5 39 2.602e-06 3.289e-05
369 SEX DIFFERENTIATION 10 266 2.728e-06 3.44e-05
370 REGULATION OF CELL MATURATION 4 18 2.781e-06 3.488e-05
371 PERICARDIUM DEVELOPMENT 4 18 2.781e-06 3.488e-05
372 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 7 109 2.825e-06 3.533e-05
373 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 8 156 2.929e-06 3.654e-05
374 REGULATION OF MEIOTIC CELL CYCLE 5 40 2.96e-06 3.673e-05
375 POSITIVE REGULATION OF CELL MATRIX ADHESION 5 40 2.96e-06 3.673e-05
376 CELL PROJECTION ORGANIZATION 18 902 2.977e-06 3.684e-05
377 REGULATION OF CELL PROJECTION ORGANIZATION 14 558 3.201e-06 3.951e-05
378 REGULATION OF CELL DIVISION 10 272 3.328e-06 4.097e-05
379 EAR MORPHOGENESIS 7 112 3.387e-06 4.159e-05
380 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 9 213 3.411e-06 4.177e-05
381 POSITIVE REGULATION OF IMMUNE RESPONSE 14 563 3.548e-06 4.333e-05
382 EMBRYONIC HEART TUBE DEVELOPMENT 6 73 3.56e-06 4.337e-05
383 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 5 43 4.272e-06 5.163e-05
384 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 5 43 4.272e-06 5.163e-05
385 MORPHOGENESIS OF AN EPITHELIAL SHEET 5 43 4.272e-06 5.163e-05
386 CELL MOTILITY 17 835 4.444e-06 5.343e-05
387 LOCALIZATION OF CELL 17 835 4.444e-06 5.343e-05
388 EPITHELIAL CELL DIFFERENTIATION 13 495 4.507e-06 5.405e-05
389 SPECIFICATION OF SYMMETRY 7 117 4.531e-06 5.42e-05
390 POSITIVE REGULATION OF LOCOMOTION 12 420 4.592e-06 5.479e-05
391 LABYRINTHINE LAYER DEVELOPMENT 5 44 4.798e-06 5.71e-05
392 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 77 4.869e-06 5.765e-05
393 REGULATION OF BMP SIGNALING PATHWAY 6 77 4.869e-06 5.765e-05
394 REGULATION OF AXONOGENESIS 8 168 5.078e-06 5.996e-05
395 REGULATION OF CYTOSKELETON ORGANIZATION 13 502 5.247e-06 6.18e-05
396 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 5.369e-06 6.292e-05
397 COCHLEA MORPHOGENESIS 4 21 5.369e-06 6.292e-05
398 ACTIVATION OF IMMUNE RESPONSE 12 427 5.432e-06 6.351e-05
399 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 122 5.979e-06 6.973e-05
400 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 9 229 6.148e-06 7.152e-05
401 LEUKOCYTE DIFFERENTIATION 10 292 6.231e-06 7.23e-05
402 KIDNEY EPITHELIUM DEVELOPMENT 7 125 7.02e-06 8.115e-05
403 KIDNEY MORPHOGENESIS 6 82 7.028e-06 8.115e-05
404 OSTEOBLAST DIFFERENTIATION 7 126 7.399e-06 8.5e-05
405 RESPONSE TO UV 7 126 7.399e-06 8.5e-05
406 ANTERIOR POSTERIOR AXIS SPECIFICATION 5 48 7.43e-06 8.515e-05
407 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 11 368 7.671e-06 8.77e-05
408 REGULATION OF OSTEOBLAST PROLIFERATION 4 23 7.874e-06 8.958e-05
409 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 4 23 7.874e-06 8.958e-05
410 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 6 84 8.084e-06 9.152e-05
411 POSITIVE REGULATION OF OSSIFICATION 6 84 8.084e-06 9.152e-05
412 MUSCLE CELL DIFFERENTIATION 9 237 8.11e-06 9.159e-05
413 REGULATION OF PHOSPHATASE ACTIVITY 7 128 8.207e-06 9.246e-05
414 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 9.112e-06 0.0001024
415 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 9.408e-06 0.0001052
416 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 4 24 9.408e-06 0.0001052
417 MACROMOLECULAR COMPLEX ASSEMBLY 22 1398 9.974e-06 0.0001113
418 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 5 51 1.006e-05 0.0001114
419 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 51 1.006e-05 0.0001114
420 MAINTENANCE OF CELL NUMBER 7 132 1.004e-05 0.0001114
421 RESPONSE TO OXYGEN LEVELS 10 311 1.081e-05 0.0001192
422 HEMOSTASIS 10 311 1.081e-05 0.0001192
423 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 9 246 1.094e-05 0.0001203
424 NEGATIVE REGULATION OF TRANSPORT 12 458 1.1e-05 0.0001208
425 REGULATION OF ACTIN FILAMENT BASED PROCESS 10 312 1.111e-05 0.0001217
426 LENS FIBER CELL DIFFERENTIATION 4 25 1.115e-05 0.0001218
427 EPITHELIAL CELL PROLIFERATION 6 89 1.13e-05 0.0001231
428 REGULATION OF CELL MATRIX ADHESION 6 90 1.205e-05 0.0001307
429 MESONEPHROS DEVELOPMENT 6 90 1.205e-05 0.0001307
430 TAXIS 12 464 1.253e-05 0.000135
431 PROTEIN DEPHOSPHORYLATION 8 190 1.251e-05 0.000135
432 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 190 1.251e-05 0.000135
433 CELLULAR RESPONSE TO RADIATION 7 137 1.281e-05 0.0001376
434 OSSIFICATION 9 251 1.284e-05 0.0001377
435 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 8 191 1.3e-05 0.000139
436 REGULATION OF CELL FATE COMMITMENT 4 26 1.312e-05 0.00014
437 PLACENTA DEVELOPMENT 7 138 1.343e-05 0.000143
438 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 15 724 1.397e-05 0.0001484
439 MITOTIC CELL CYCLE CHECKPOINT 7 139 1.408e-05 0.0001492
440 REGULATION OF PEPTIDE TRANSPORT 9 256 1.502e-05 0.0001589
441 REGULATION OF MUSCLE SYSTEM PROCESS 8 195 1.51e-05 0.0001594
442 DEVELOPMENTAL INDUCTION 4 27 1.534e-05 0.0001611
443 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 1.534e-05 0.0001611
444 SYSTEM PROCESS 25 1785 1.672e-05 0.0001752
445 RESPONSE TO INORGANIC SUBSTANCE 12 479 1.718e-05 0.0001797
446 NEURON PROJECTION MORPHOGENESIS 11 402 1.751e-05 0.0001826
447 CARDIAC CHAMBER DEVELOPMENT 7 144 1.771e-05 0.0001842
448 REGULATION OF CYTOKINE PRODUCTION 13 563 1.779e-05 0.0001842
449 GASTRULATION WITH MOUTH FORMING SECOND 4 28 1.781e-05 0.0001842
450 MORPHOGENESIS OF A POLARIZED EPITHELIUM 4 28 1.781e-05 0.0001842
451 NEGATIVE REGULATION OF LOCOMOTION 9 263 1.861e-05 0.000192
452 CELLULAR RESPONSE TO EXTERNAL STIMULUS 9 264 1.917e-05 0.0001974
453 RESPONSE TO METAL ION 10 333 1.95e-05 0.0002003
454 REGULATION OF NEURON PROJECTION DEVELOPMENT 11 408 2.007e-05 0.0002057
455 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 6 99 2.081e-05 0.0002128
456 ACTIVATION OF INNATE IMMUNE RESPONSE 8 204 2.091e-05 0.0002134
457 NEURON PROJECTION GUIDANCE 8 205 2.166e-05 0.0002206
458 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 2.203e-05 0.0002239
459 RESPONSE TO RADIATION 11 413 2.245e-05 0.0002276
460 RESPONSE TO EXTERNAL STIMULUS 25 1821 2.346e-05 0.0002373
461 POSITIVE REGULATION OF STEM CELL PROLIFERATION 5 61 2.435e-05 0.0002458
462 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 102 2.466e-05 0.0002484
463 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 8 209 2.488e-05 0.0002495
464 LYMPHOCYTE DIFFERENTIATION 8 209 2.488e-05 0.0002495
465 PALLIUM DEVELOPMENT 7 153 2.62e-05 0.0002622
466 COVALENT CHROMATIN MODIFICATION 10 345 2.638e-05 0.0002634
467 SKIN DEVELOPMENT 8 211 2.664e-05 0.0002654
468 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 4 31 2.702e-05 0.0002686
469 AMEBOIDAL TYPE CELL MIGRATION 7 154 2.732e-05 0.0002711
470 CARDIAC CHAMBER MORPHOGENESIS 6 104 2.754e-05 0.0002726
471 POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 3 11 2.804e-05 0.000277
472 REGULATION OF CHROMOSOME ORGANIZATION 9 278 2.879e-05 0.0002838
473 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 10 351 3.054e-05 0.0003005
474 NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 5 64 3.079e-05 0.000301
475 REGULATION OF ORGAN FORMATION 4 32 3.075e-05 0.000301
476 PATTERNING OF BLOOD VESSELS 4 32 3.075e-05 0.000301
477 REGULATION OF DEPHOSPHORYLATION 7 158 3.221e-05 0.0003142
478 NEGATIVE REGULATION OF AXONOGENESIS 5 65 3.321e-05 0.0003233
479 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 6 108 3.41e-05 0.0003312
480 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 33 3.484e-05 0.0003377
481 CELLULAR RESPONSE TO UV 5 66 3.577e-05 0.0003453
482 FOREBRAIN GENERATION OF NEURONS 5 66 3.577e-05 0.0003453
483 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 3 12 3.723e-05 0.0003557
484 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 3 12 3.723e-05 0.0003557
485 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 3.723e-05 0.0003557
486 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 3.723e-05 0.0003557
487 LENS FIBER CELL DEVELOPMENT 3 12 3.723e-05 0.0003557
488 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 437 3.761e-05 0.0003579
489 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 19 1193 3.755e-05 0.0003579
490 APOPTOTIC SIGNALING PATHWAY 9 289 3.897e-05 0.0003701
491 NEURAL TUBE PATTERNING 4 34 3.931e-05 0.0003725
492 REGULATION OF SECRETION 14 699 4e-05 0.0003783
493 REGULATION OF GASTRULATION 4 35 4.419e-05 0.0004171
494 POSITIVE REGULATION OF AXONOGENESIS 5 69 4.438e-05 0.0004172
495 SYNAPSE ASSEMBLY 5 69 4.438e-05 0.0004172
496 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 7 167 4.587e-05 0.0004303
497 TELENCEPHALON DEVELOPMENT 8 228 4.621e-05 0.0004326
498 RESPONSE TO CARBOHYDRATE 7 168 4.764e-05 0.0004443
499 POSITIVE REGULATION OF CYTOKINE PRODUCTION 10 370 4.765e-05 0.0004443
500 REGULATION OF SKELETAL MUSCLE ADAPTATION 3 13 4.82e-05 0.0004485
501 RESPONSE TO CALCIUM ION 6 115 4.856e-05 0.000451
502 CHROMOSOME ORGANIZATION 17 1009 5.066e-05 0.0004696
503 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 71 5.095e-05 0.0004714
504 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 8 232 5.224e-05 0.0004813
505 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 8 232 5.224e-05 0.0004813
506 MODULATION OF SYNAPTIC TRANSMISSION 9 301 5.34e-05 0.0004911
507 REGULATION OF VASCULATURE DEVELOPMENT 8 233 5.385e-05 0.0004942
508 CHROMATIN MODIFICATION 12 539 5.423e-05 0.0004967
509 REGULATION OF MUSCLE HYPERTROPHY 4 37 5.525e-05 0.0005051
510 STRIATED MUSCLE CELL DIFFERENTIATION 7 173 5.737e-05 0.0005234
511 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 5 73 5.826e-05 0.0005294
512 POSITIVE REGULATION OF PROTEIN BINDING 5 73 5.826e-05 0.0005294
513 CELL MIGRATION INVOLVED IN GASTRULATION 3 14 6.109e-05 0.000553
514 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 6.109e-05 0.000553
515 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 6 121 6.454e-05 0.0005831
516 NEURAL CREST CELL DIFFERENTIATION 5 75 6.635e-05 0.0005983
517 COCHLEA DEVELOPMENT 4 39 6.822e-05 0.000614
518 POSITIVE REGULATION OF MITOTIC CELL CYCLE 6 123 7.071e-05 0.0006339
519 T CELL DIFFERENTIATION 6 123 7.071e-05 0.0006339
520 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 40 7.547e-05 0.0006753
521 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 7.605e-05 0.0006792
522 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 4 41 8.326e-05 0.0007422
523 REGULATION OF HORMONE LEVELS 11 478 8.41e-05 0.0007482
524 POSITIVE REGULATION OF BINDING 6 127 8.446e-05 0.00075
525 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 6 128 8.821e-05 0.0007803
526 MUSCLE CELL DEVELOPMENT 6 128 8.821e-05 0.0007803
527 COGNITION 8 251 9.06e-05 0.0007984
528 EPITHELIAL CELL DEVELOPMENT 7 186 9.05e-05 0.0007984
529 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 4 42 9.163e-05 0.000806
530 REGULATION OF REPRODUCTIVE PROCESS 6 129 9.209e-05 0.0008085
531 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 3 16 9.321e-05 0.0008153
532 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 9.321e-05 0.0008153
533 CHROMATIN ORGANIZATION 13 663 9.51e-05 0.0008302
534 REGULATION OF FIBROBLAST PROLIFERATION 5 81 9.588e-05 0.0008354
535 PROTEIN STABILIZATION 6 131 0.0001003 0.000872
536 JNK CASCADE 5 82 0.0001016 0.0008824
537 NEGATIVE REGULATION OF PROTEOLYSIS 9 329 0.0001054 0.0009132
538 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.0001077 0.0009313
539 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 7 192 0.0001103 0.0009525
540 CELL CYCLE CHECKPOINT 7 194 0.0001177 0.001014
541 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 6 135 0.0001183 0.001018
542 CARDIAC SEPTUM DEVELOPMENT 5 85 0.0001206 0.001035
543 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 7 195 0.0001215 0.001039
544 EAR DEVELOPMENT 7 195 0.0001215 0.001039
545 REGULATION OF HORMONE SECRETION 8 262 0.0001219 0.001041
546 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 7 197 0.0001294 0.001103
547 UTERUS DEVELOPMENT 3 18 0.0001347 0.001144
548 SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 3 18 0.0001347 0.001144
549 REGULATION OF DNA METABOLIC PROCESS 9 340 0.0001351 0.001145
550 CELLULAR RESPONSE TO NITROGEN COMPOUND 11 505 0.0001364 0.001154
551 REGULATION OF BODY FLUID LEVELS 11 506 0.0001388 0.001172
552 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 0.0001421 0.001198
553 REGULATION OF SYNAPTIC PLASTICITY 6 140 0.0001445 0.001215
554 SYNAPTIC SIGNALING 10 424 0.0001467 0.001232
555 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 6 141 0.0001502 0.001259
556 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 4 48 0.0001552 0.001299
557 NEGATIVE REGULATION OF CATABOLIC PROCESS 7 203 0.0001558 0.001302
558 ENDOTHELIUM DEVELOPMENT 5 90 0.000158 0.001317
559 POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 3 19 0.0001593 0.001326
560 CELLULAR RESPONSE TO CYTOKINE STIMULUS 12 606 0.0001636 0.00136
561 PROTEIN LOCALIZATION 23 1805 0.0001646 0.001365
562 CELLULAR RESPONSE TO LIGHT STIMULUS 5 91 0.0001664 0.001378
563 CARDIAC SEPTUM MORPHOGENESIS 4 49 0.0001683 0.001391
564 HOMEOSTATIC PROCESS 19 1337 0.0001698 0.001401
565 SYNAPSE ORGANIZATION 6 145 0.000175 0.001438
566 NEGATIVE REGULATION OF MAPK CASCADE 6 145 0.000175 0.001438
567 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 207 0.0001757 0.001442
568 MUSCLE ORGAN DEVELOPMENT 8 277 0.0001785 0.001462
569 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 6 146 0.0001816 0.001484
570 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.0001821 0.001484
571 RHO PROTEIN SIGNAL TRANSDUCTION 4 50 0.0001821 0.001484
572 REGULATION OF DNA BINDING 5 93 0.0001843 0.001499
573 TONGUE DEVELOPMENT 3 20 0.0001867 0.001505
574 TRACHEA DEVELOPMENT 3 20 0.0001867 0.001505
575 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 3 20 0.0001867 0.001505
576 REGULATION OF PEPTIDE SECRETION 7 209 0.0001864 0.001505
577 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 0.0001867 0.001505
578 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 6 147 0.0001885 0.001517
579 RESPONSE TO LIGHT STIMULUS 8 280 0.0001921 0.001544
580 REGULATION OF INNATE IMMUNE RESPONSE 9 357 0.0001945 0.001561
581 MALE SEX DIFFERENTIATION 6 148 0.0001956 0.001566
582 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 95 0.0002036 0.001628
583 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 3 21 0.0002169 0.001731
584 DEPHOSPHORYLATION 8 286 0.0002218 0.001767
585 POSITIVE REGULATION OF DEFENSE RESPONSE 9 364 0.0002246 0.001787
586 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 0.000226 0.001794
587 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 4 53 0.0002285 0.001805
588 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 4 53 0.0002285 0.001805
589 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 7 216 0.0002281 0.001805
590 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 5 98 0.0002355 0.001857
591 REGULATION OF MITOCHONDRION ORGANIZATION 7 218 0.0002412 0.001899
592 CELL PART MORPHOGENESIS 12 633 0.0002443 0.00192
593 CEREBRAL CORTEX NEURON DIFFERENTIATION 3 22 0.0002501 0.001946
594 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 3 22 0.0002501 0.001946
595 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 3 22 0.0002501 0.001946
596 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 3 22 0.0002501 0.001946
597 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 3 22 0.0002501 0.001946
598 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0002501 0.001946
599 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.000271 0.002105
600 SMAD PROTEIN SIGNAL TRANSDUCTION 4 56 0.0002829 0.002191
601 INOSITOL PHOSPHATE METABOLIC PROCESS 4 56 0.0002829 0.002191
602 NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 3 23 0.0002864 0.002214
603 CELLULAR RESPONSE TO HORMONE STIMULUS 11 552 0.0002938 0.002267
604 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 0.0002969 0.002287
605 MYOTUBE DIFFERENTIATION 4 57 0.000303 0.00233
606 REGENERATION 6 161 0.000308 0.002365
607 CEREBRAL CORTEX DEVELOPMENT 5 105 0.0003245 0.002488
608 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 3 24 0.000326 0.002495
609 REGULATION OF NUCLEAR DIVISION 6 163 0.0003291 0.00251
610 CELLULAR RESPONSE TO BIOTIC STIMULUS 6 163 0.0003291 0.00251
611 VASCULOGENESIS 4 59 0.0003461 0.002635
612 POSITIVE REGULATION OF NEURON DIFFERENTIATION 8 306 0.0003493 0.002656
613 REGULATION OF EPITHELIAL CELL MIGRATION 6 166 0.0003628 0.002754
614 REGULATION OF PROTEIN SECRETION 9 389 0.0003657 0.002772
615 NEGATIVE REGULATION OF CELL DIVISION 4 60 0.0003692 0.00278
616 SPINDLE CHECKPOINT 3 25 0.0003689 0.00278
617 NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 3 25 0.0003689 0.00278
618 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 60 0.0003692 0.00278
619 REGULATION OF PEPTIDASE ACTIVITY 9 392 0.0003868 0.002907
620 CHEMICAL HOMEOSTASIS 14 874 0.0004115 0.003088
621 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0004153 0.003112
622 CELL CYCLE G1 S PHASE TRANSITION 5 111 0.0004194 0.003132
623 G1 S TRANSITION OF MITOTIC CELL CYCLE 5 111 0.0004194 0.003132
624 REGULATION OF GTPASE ACTIVITY 12 673 0.0004248 0.003167
625 REGULATION OF CELL SIZE 6 172 0.0004382 0.003262
626 PROTEIN CATABOLIC PROCESS 11 579 0.0004396 0.003268
627 REGULATION OF CARTILAGE DEVELOPMENT 4 63 0.0004452 0.003304
628 SKELETAL MUSCLE TISSUE REGENERATION 3 27 0.0004653 0.003431
629 REGULATION OF MICROTUBULE BASED PROCESS 7 243 0.0004644 0.003431
630 NEGATIVE REGULATION OF AXON GUIDANCE 3 27 0.0004653 0.003431
631 RESPONSE TO LITHIUM ION 3 27 0.0004653 0.003431
632 REGULATION OF ENDOTHELIAL CELL MIGRATION 5 114 0.000474 0.003489
633 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 6 175 0.0004803 0.00353
634 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 5 115 0.0004933 0.003603
635 RESPONSE TO INTERLEUKIN 1 5 115 0.0004933 0.003603
636 CELLULAR RESPONSE TO ALCOHOL 5 115 0.0004933 0.003603
637 NEPHRON DEVELOPMENT 5 115 0.0004933 0.003603
638 MITOCHONDRIAL TRANSPORT 6 177 0.00051 0.00372
639 VENTRICULAR SEPTUM MORPHOGENESIS 3 28 0.000519 0.00375
640 RESPONSE TO STEROID HORMONE 10 497 0.0005181 0.00375
641 PLACENTA BLOOD VESSEL DEVELOPMENT 3 28 0.000519 0.00375
642 NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 3 28 0.000519 0.00375
643 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.000519 0.00375
644 MAMMARY GLAND DUCT MORPHOGENESIS 3 28 0.000519 0.00375
645 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 12 689 0.0005235 0.003776
646 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.0005337 0.003844
647 REGULATION OF CHEMOTAXIS 6 180 0.0005573 0.004008
648 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 67 0.000563 0.004024
649 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 4 67 0.000563 0.004024
650 CELLULAR RESPONSE TO DRUG 4 67 0.000563 0.004024
651 REGULATION OF SISTER CHROMATID SEGREGATION 4 67 0.000563 0.004024
652 NEUROBLAST PROLIFERATION 3 29 0.0005765 0.004114
653 RESPONSE TO KETONE 6 182 0.0005906 0.004209
654 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 0.0005956 0.004231
655 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 4 68 0.0005956 0.004231
656 REGULATION OF DENDRITE DEVELOPMENT 5 120 0.000599 0.004249
657 REGULATION OF SYSTEM PROCESS 10 507 0.0006045 0.004281
658 REGULATION OF MYELOID CELL DIFFERENTIATION 6 183 0.0006079 0.004299
659 NEGATIVE REGULATION OF OSSIFICATION 4 69 0.0006295 0.004445
660 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 30 0.000638 0.004477
661 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 3 30 0.000638 0.004477
662 RESPONSE TO X RAY 3 30 0.000638 0.004477
663 MYOTUBE CELL DEVELOPMENT 3 30 0.000638 0.004477
664 CELLULAR RESPONSE TO INTERFERON GAMMA 5 122 0.0006458 0.004525
665 MUSCLE ORGAN MORPHOGENESIS 4 70 0.0006648 0.004637
666 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 4 70 0.0006648 0.004637
667 REGULATION OF MEMBRANE PERMEABILITY 4 70 0.0006648 0.004637
668 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 6 188 0.0007001 0.004864
669 SKIN EPIDERMIS DEVELOPMENT 4 71 0.0007014 0.004864
670 ENDODERM DEVELOPMENT 4 71 0.0007014 0.004864
671 CELL FATE SPECIFICATION 4 71 0.0007014 0.004864
672 ENDOTHELIAL CELL DIFFERENTIATION 4 72 0.0007395 0.00512
673 EMBRYONIC FORELIMB MORPHOGENESIS 3 32 0.000773 0.005321
674 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 3 32 0.000773 0.005321
675 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 3 32 0.000773 0.005321
676 ADIPOSE TISSUE DEVELOPMENT 3 32 0.000773 0.005321
677 PANCREAS DEVELOPMENT 4 73 0.0007789 0.005354
678 HEPATICOBILIARY SYSTEM DEVELOPMENT 5 128 0.0008024 0.005507
679 REGULATION OF DENDRITE MORPHOGENESIS 4 74 0.0008199 0.005602
680 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 4 74 0.0008199 0.005602
681 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 74 0.0008199 0.005602
682 PROTEIN ACETYLATION 5 129 0.0008311 0.00567
683 REGULATION OF PROTEIN EXPORT FROM NUCLEUS 3 33 0.0008468 0.005769
684 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 352 0.0008756 0.005956
685 RESPONSE TO EXTRACELLULAR STIMULUS 9 441 0.0008972 0.006095
686 FOREBRAIN NEURON DEVELOPMENT 3 34 0.000925 0.006256
687 REGULATION OF PROTEIN DEACETYLATION 3 34 0.000925 0.006256
688 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 3 34 0.000925 0.006256
689 MUSCLE TISSUE DEVELOPMENT 7 275 0.0009625 0.0065
690 RENAL TUBULE DEVELOPMENT 4 78 0.000999 0.006737
691 BONE REMODELING 3 35 0.001008 0.006775
692 RESPONSE TO MINERALOCORTICOID 3 35 0.001008 0.006775
693 ACTIN FILAMENT BASED PROCESS 9 450 0.001034 0.00694
694 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 5 136 0.001053 0.007063
695 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 7 280 0.001069 0.007154
696 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 36 0.001095 0.007297
697 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.001095 0.007297
698 HEAD MORPHOGENESIS 3 36 0.001095 0.007297
699 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 4 81 0.00115 0.007646
700 NUCLEAR ENVELOPE ORGANIZATION 4 81 0.00115 0.007646
701 POSITIVE REGULATION OF SECRETION 8 370 0.001205 0.007999
702 REGULATION OF DEFENSE RESPONSE 12 759 0.001213 0.008041
703 PROTEOLYSIS 16 1208 0.001235 0.008176
704 RESPONSE TO MECHANICAL STIMULUS 6 210 0.001241 0.008203
705 HAIR CYCLE 4 83 0.001259 0.008289
706 NIK NF KAPPAB SIGNALING 4 83 0.001259 0.008289
707 MOLTING CYCLE 4 83 0.001259 0.008289
708 NEGATIVE REGULATION OF AXON EXTENSION 3 38 0.001283 0.008418
709 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 3 38 0.001283 0.008418
710 ENDOMEMBRANE SYSTEM ORGANIZATION 9 465 0.001298 0.008506
711 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 4 84 0.001317 0.008572
712 CELLULAR RESPONSE TO OXYGEN LEVELS 5 143 0.001317 0.008572
713 RAS PROTEIN SIGNAL TRANSDUCTION 5 143 0.001317 0.008572
714 REGULATION OF PROTEIN COMPLEX ASSEMBLY 8 375 0.001312 0.008572
715 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 5 143 0.001317 0.008572
716 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 6 213 0.001335 0.008672
717 RESPONSE TO INTERFERON GAMMA 5 144 0.001359 0.008816
718 NEGATIVE REGULATION OF CELL CYCLE PROCESS 6 214 0.001367 0.008857
719 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 4 85 0.001376 0.008879
720 REGULATION OF CHROMOSOME SEGREGATION 4 85 0.001376 0.008879
721 EPHRIN RECEPTOR SIGNALING PATHWAY 4 85 0.001376 0.008879
722 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 3 39 0.001384 0.008895
723 REGULATION OF AXON GUIDANCE 3 39 0.001384 0.008895
724 TRABECULA MORPHOGENESIS 3 39 0.001384 0.008895
725 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 5 145 0.001401 0.00899
726 RESPONSE TO ESTRADIOL 5 146 0.001444 0.009242
727 T CELL RECEPTOR SIGNALING PATHWAY 5 146 0.001444 0.009242
728 MAMMARY GLAND MORPHOGENESIS 3 40 0.00149 0.009511
729 FORELIMB MORPHOGENESIS 3 40 0.00149 0.009511
730 RESPONSE TO ESTROGEN 6 218 0.001502 0.009573
731 SINGLE ORGANISM BEHAVIOR 8 384 0.001524 0.009703
732 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 4 88 0.001564 0.009942
NumGOOverlapSizeP ValueAdj. P Value
1 BETA CATENIN BINDING 20 84 1.5e-27 1.103e-24
2 FRIZZLED BINDING 16 36 2.374e-27 1.103e-24
3 WNT ACTIVATED RECEPTOR ACTIVITY 14 22 4.517e-27 1.399e-24
4 WNT PROTEIN BINDING 14 31 3.593e-24 8.344e-22
5 PROTEIN SERINE THREONINE KINASE ACTIVITY 23 445 5.096e-16 9.469e-14
6 ENZYME BINDING 38 1737 8.493e-14 1.315e-11
7 PROTEIN KINASE ACTIVITY 24 640 1.309e-13 1.737e-11
8 RECEPTOR AGONIST ACTIVITY 7 16 1.67e-12 1.552e-10
9 TRANSCRIPTION FACTOR BINDING 21 524 1.536e-12 1.552e-10
10 G PROTEIN COUPLED RECEPTOR BINDING 16 259 1.423e-12 1.552e-10
11 SIGNAL TRANSDUCER ACTIVITY 35 1731 1.074e-11 9.068e-10
12 KINASE ACTIVITY 24 842 4.313e-11 3.082e-09
13 PROTEIN DOMAIN SPECIFIC BINDING 21 624 4.097e-11 3.082e-09
14 RECEPTOR ACTIVATOR ACTIVITY 7 32 4.562e-10 2.825e-08
15 RECEPTOR BINDING 30 1476 4.334e-10 2.825e-08
16 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 24 992 1.191e-09 6.915e-08
17 REGULATORY REGION NUCLEIC ACID BINDING 21 818 5.441e-09 2.901e-07
18 MOLECULAR FUNCTION REGULATOR 27 1353 5.934e-09 2.901e-07
19 RECEPTOR REGULATOR ACTIVITY 7 45 5.79e-09 2.901e-07
20 ARMADILLO REPEAT DOMAIN BINDING 5 13 6.538e-09 3.037e-07
21 KINASE BINDING 18 606 8.363e-09 3.7e-07
22 CORE PROMOTER PROXIMAL REGION DNA BINDING 14 371 2.331e-08 9.841e-07
23 UBIQUITIN LIKE PROTEIN LIGASE BINDING 12 264 3.306e-08 1.335e-06
24 PDZ DOMAIN BINDING 8 90 4.263e-08 1.65e-06
25 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 17 629 8.879e-08 3.299e-06
26 PROTEIN DIMERIZATION ACTIVITY 23 1149 9.4e-08 3.359e-06
27 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 8 104 1.327e-07 4.566e-06
28 SMAD BINDING 7 72 1.658e-07 5.501e-06
29 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 12 315 2.258e-07 7.235e-06
30 GAMMA CATENIN BINDING 4 12 4.618e-07 1.43e-05
31 CALMODULIN BINDING 9 179 8.092e-07 2.425e-05
32 MAP KINASE ACTIVITY 4 14 9.257e-07 2.688e-05
33 RIBONUCLEOTIDE BINDING 28 1860 1.102e-06 3.102e-05
34 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 11 328 2.563e-06 7.003e-05
35 ADENYL NUCLEOTIDE BINDING 24 1514 3.193e-06 8.474e-05
36 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 4 21 5.369e-06 0.0001348
37 SEQUENCE SPECIFIC DNA BINDING 19 1037 5.289e-06 0.0001348
38 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 226 5.525e-06 0.0001351
39 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 14 588 5.838e-06 0.0001391
40 RECEPTOR SIGNALING PROTEIN ACTIVITY 8 172 6.04e-06 0.0001403
41 R SMAD BINDING 4 23 7.874e-06 0.0001784
42 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 20 1199 1.165e-05 0.0002576
43 CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 4 28 1.781e-05 0.0003761
44 ACTIVATING TRANSCRIPTION FACTOR BINDING 5 57 1.745e-05 0.0003761
45 DOUBLE STRANDED DNA BINDING 15 764 2.614e-05 0.0005396
46 PHOSPHOLIPASE C ACTIVITY 4 31 2.702e-05 0.0005457
47 I SMAD BINDING 3 11 2.804e-05 0.0005542
48 PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 5 64 3.079e-05 0.0005959
49 CHROMATIN BINDING 11 435 3.608e-05 0.000684
50 CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 3 12 3.723e-05 0.0006917
51 PHOSPHORIC ESTER HYDROLASE ACTIVITY 10 368 4.553e-05 0.0008293
52 TRANSCRIPTION COACTIVATOR ACTIVITY 9 296 4.692e-05 0.0008382
53 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 4 36 4.95e-05 0.0008676
54 PROTEIN HOMODIMERIZATION ACTIVITY 14 722 5.672e-05 0.0009758
55 PROTEIN HETERODIMERIZATION ACTIVITY 11 468 6.968e-05 0.001177
56 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 3 15 7.605e-05 0.001262
57 RHO GTPASE BINDING 5 78 8.007e-05 0.001305
58 PROTEIN KINASE C ACTIVITY 3 16 9.321e-05 0.001493
59 ENZYME REGULATOR ACTIVITY 16 959 9.662e-05 0.001521
60 PHOSPHATASE REGULATOR ACTIVITY 5 87 0.0001346 0.002084
61 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 5 92 0.0001752 0.002668
62 ENHANCER BINDING 5 93 0.0001843 0.002762
63 MACROMOLECULAR COMPLEX BINDING 19 1399 0.0003024 0.00446
64 MITOGEN ACTIVATED PROTEIN KINASE BINDING 3 24 0.000326 0.004732
65 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 6 168 0.0003867 0.005443
66 DRUG BINDING 5 109 0.0003857 0.005443
67 IDENTICAL PROTEIN BINDING 17 1209 0.0004388 0.006084
68 BHLH TRANSCRIPTION FACTOR BINDING 3 28 0.000519 0.007074
69 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 6 178 0.0005254 0.007074
70 P53 BINDING 4 67 0.000563 0.007471
71 NF KAPPAB BINDING 3 30 0.000638 0.008347
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALOSOME 8 11 1.313e-16 7.669e-14
2 BETA CATENIN DESTRUCTION COMPLEX 8 14 2.357e-15 6.881e-13
3 ENDOCYTIC VESICLE MEMBRANE 13 152 3.355e-12 6.532e-10
4 PHOSPHATASE COMPLEX 9 48 5.92e-12 8.643e-10
5 CATALYTIC COMPLEX 26 1038 9.908e-11 1.157e-08
6 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 6 20 1.034e-09 1.006e-07
7 ENDOCYTIC VESICLE 13 256 2.251e-09 1.878e-07
8 CHROMOSOME 22 880 3.616e-09 2.64e-07
9 NUCLEAR CHROMATIN 13 291 1.05e-08 6.813e-07
10 TRANSCRIPTION FACTOR COMPLEX 13 298 1.393e-08 8.135e-07
11 CHROMATIN 15 441 2.812e-08 1.493e-06
12 SYNAPSE 18 754 2.269e-07 1.104e-05
13 EXTRACELLULAR MATRIX 13 426 8.626e-07 3.598e-05
14 PROTEINACEOUS EXTRACELLULAR MATRIX 12 356 8.29e-07 3.598e-05
15 VESICLE MEMBRANE 14 512 1.173e-06 4.568e-05
16 TRANSCRIPTIONAL REPRESSOR COMPLEX 6 74 3.857e-06 0.0001408
17 CELL SURFACE 16 757 5.466e-06 0.0001878
18 INTRACELLULAR VESICLE 21 1259 6.795e-06 0.0002205
19 CYTOPLASMIC VESICLE PART 14 601 7.485e-06 0.0002301
20 NUCLEAR CHROMOSOME 13 523 8.15e-06 0.000238
21 PROTEIN KINASE COMPLEX 6 90 1.205e-05 0.000335
22 GOLGI LUMEN 6 94 1.547e-05 0.0004106
23 SCF UBIQUITIN LIGASE COMPLEX 4 34 3.931e-05 0.000994
24 TRANSFERASE COMPLEX 14 703 4.255e-05 0.000994
25 SYNAPSE PART 13 610 4.089e-05 0.000994
26 CYTOSKELETAL PART 21 1436 4.85e-05 0.001089
27 LAMELLIPODIUM 7 172 5.531e-05 0.001196
28 CHROMOSOME CENTROMERIC REGION 7 174 5.95e-05 0.001241
29 CYTOSKELETON 25 1967 8.374e-05 0.001644
30 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 6 127 8.446e-05 0.001644
31 MICROTUBULE CYTOSKELETON 17 1068 0.0001017 0.001917
32 NUCLEAR ENVELOPE 10 416 0.0001256 0.002291
33 EXCITATORY SYNAPSE 7 197 0.0001294 0.002291
34 LATERAL PLASMA MEMBRANE 4 50 0.0001821 0.003038
35 NUCLEOPLASM PART 13 708 0.0001821 0.003038
36 NUCLEAR MEMBRANE 8 280 0.0001921 0.003116
37 MICROTUBULE ORGANIZING CENTER 12 623 0.0002112 0.003333
38 NEURONAL POSTSYNAPTIC DENSITY 4 53 0.0002285 0.003512
39 CELL PROJECTION 22 1786 0.0003763 0.005635
40 CENTROSOME 10 487 0.0004423 0.006458
41 ACTIN FILAMENT 4 70 0.0006648 0.009469
42 NEURON PART 17 1265 0.0007318 0.009713
43 SARCOLEMMA 5 125 0.0007209 0.009713
44 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 3 31 0.0007034 0.009713

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04310_Wnt_signaling_pathway 113 151 2.181e-266 3.926e-264
2 hsa04916_Melanogenesis 42 101 2.453e-70 2.207e-68
3 hsa04390_Hippo_signaling_pathway 42 154 4.692e-61 2.815e-59
4 hsa04340_Hedgehog_signaling_pathway 19 56 1.42e-29 6.39e-28
5 hsa04720_Long.term_potentiation 19 70 1.994e-27 7.177e-26
6 hsa04520_Adherens_junction 17 73 2.368e-23 7.103e-22
7 hsa04114_Oocyte_meiosis 19 114 5.217e-23 1.342e-21
8 hsa04912_GnRH_signaling_pathway 17 101 9.427e-21 2.121e-19
9 hsa04010_MAPK_signaling_pathway 21 268 2.483e-18 4.967e-17
10 hsa04971_Gastric_acid_secretion 14 74 5.061e-18 9.109e-17
11 hsa04662_B_cell_receptor_signaling_pathway 14 75 6.193e-18 1.013e-16
12 hsa04370_VEGF_signaling_pathway 14 76 7.557e-18 1.134e-16
13 hsa04020_Calcium_signaling_pathway 17 177 1.741e-16 2.41e-15
14 hsa04360_Axon_guidance 15 130 7.22e-16 9.283e-15
15 hsa04510_Focal_adhesion 17 200 1.373e-15 1.648e-14
16 hsa04350_TGF.beta_signaling_pathway 13 85 1.548e-15 1.741e-14
17 hsa04012_ErbB_signaling_pathway 13 87 2.123e-15 2.248e-14
18 hsa04650_Natural_killer_cell_mediated_cytotoxicity 14 136 3.537e-14 3.537e-13
19 hsa04660_T_cell_receptor_signaling_pathway 13 108 3.875e-14 3.671e-13
20 hsa04270_Vascular_smooth_muscle_contraction 13 116 9.974e-14 8.976e-13
21 hsa04062_Chemokine_signaling_pathway 14 189 3.38e-12 2.897e-11
22 hsa04722_Neurotrophin_signaling_pathway 12 127 7.278e-12 5.955e-11
23 hsa04110_Cell_cycle 12 128 7.994e-12 6.256e-11
24 hsa04970_Salivary_secretion 10 89 7.738e-11 5.803e-10
25 hsa04540_Gap_junction 10 90 8.664e-11 6.238e-10
26 hsa04380_Osteoclast_differentiation 11 128 1.597e-10 1.106e-09
27 hsa04730_Long.term_depression 9 70 2.07e-10 1.38e-09
28 hsa04972_Pancreatic_secretion 9 101 5.749e-09 3.696e-08
29 hsa04014_Ras_signaling_pathway 12 236 9.522e-09 5.91e-08
30 hsa04664_Fc_epsilon_RI_signaling_pathway 8 79 1.511e-08 9.064e-08
31 hsa04710_Circadian_rhythm_._mammal 5 23 1.634e-07 9.487e-07
32 hsa04070_Phosphatidylinositol_signaling_system 7 78 2.892e-07 1.627e-06
33 hsa04670_Leukocyte_transendothelial_migration 8 117 3.306e-07 1.803e-06
34 hsa04151_PI3K_AKT_signaling_pathway 12 351 7.143e-07 3.781e-06
35 hsa04530_Tight_junction 8 133 8.815e-07 4.534e-06
36 hsa04330_Notch_signaling_pathway 5 47 6.686e-06 3.343e-05
37 hsa04914_Progesterone.mediated_oocyte_maturation 6 87 9.906e-06 4.819e-05
38 hsa04210_Apoptosis 6 89 1.13e-05 5.351e-05
39 hsa04910_Insulin_signaling_pathway 7 138 1.343e-05 6.199e-05
40 hsa04620_Toll.like_receptor_signaling_pathway 6 102 2.466e-05 0.000111
41 hsa04810_Regulation_of_actin_cytoskeleton 8 214 2.947e-05 0.0001294
42 hsa03015_mRNA_surveillance_pathway 5 83 0.0001077 0.0004615
43 hsa04666_Fc_gamma_R.mediated_phagocytosis 5 95 0.0002036 0.0008525
44 hsa04742_Taste_transduction 4 52 0.0002122 0.0008681
45 hsa04630_Jak.STAT_signaling_pathway 6 155 0.0002511 0.001004
46 hsa00562_Inositol_phosphate_metabolism 4 57 0.000303 0.001186
47 hsa04621_NOD.like_receptor_signaling_pathway 4 59 0.0003461 0.001325
48 hsa04115_p53_signaling_pathway 4 69 0.0006295 0.002361
49 hsa04622_RIG.I.like_receptor_signaling_pathway 4 71 0.0007014 0.002577
50 hsa04120_Ubiquitin_mediated_proteolysis 5 139 0.001161 0.00418
51 hsa04960_Aldosterone.regulated_sodium_reabsorption 3 42 0.001717 0.006061
52 hsa04962_Vasopressin.regulated_water_reabsorption 3 44 0.001965 0.006802
53 hsa04141_Protein_processing_in_endoplasmic_reticulum 5 168 0.002666 0.009055
54 hsa04740_Olfactory_transduction 7 388 0.006526 0.02175
55 hsa04920_Adipocytokine_signaling_pathway 3 68 0.006742 0.02206
56 hsa04976_Bile_secretion 3 71 0.007595 0.02441
57 hsa04973_Carbohydrate_digestion_and_absorption 2 44 0.02565 0.08101
58 hsa03008_Ribosome_biogenesis_in_eukaryotes 2 81 0.07687 0.2386
59 hsa04144_Endocytosis 3 203 0.1078 0.3289

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MEG3

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-592;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 19 PRICKLE2 Sponge network -1.645 0.00049 -2.154 0 0.479
2

AGAP11

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-140-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-3662;hsa-miR-500a-3p 14 DAAM1 Sponge network -1.728 0.00016 -0.57 0.03626 0.478
3

KCNQ1OT1

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-100-5p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-296-5p;hsa-miR-744-3p;hsa-miR-9-5p 11 FZD5 Sponge network -0.725 0.08874 -0.562 0.20161 0.449
4

CASC2

 hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-369-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-944 12 PRKCA Sponge network -0.561 0.05962 -0.525 0.15685 0.436
5

EMX2OS

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33b-5p;hsa-miR-589-3p;hsa-miR-592;hsa-miR-7-1-3p 14 PRICKLE2 Sponge network -1.088 0.10042 -2.154 0 0.415
6

KCNQ1OT1

 hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p 11 NLK Sponge network -0.725 0.08874 0.087 0.60941 0.392
7

PCA3

 hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-616-5p 12 PRKCB Sponge network -2.778 8.0E-5 -1.403 0.00367 0.387
8

PCA3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-219a-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 28 FZD4 Sponge network -2.778 8.0E-5 -1.774 0 0.38
9

PCA3

 hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3662;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-629-3p 30 PRICKLE2 Sponge network -2.778 8.0E-5 -2.154 0 0.374
10

PART1

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-2110;hsa-miR-3614-5p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-7-1-3p 10 VANGL2 Sponge network -2.298 0.00168 -0.012 0.98605 0.367
11

CASC2

 hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-342-3p 10 NLK Sponge network -0.561 0.05962 0.087 0.60941 0.352
12 MALAT1 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-15b-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-92b-3p 13 FZD4 Sponge network -1.099 0.0005 -1.774 0 0.338
13

AGAP11

 hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-3662;hsa-miR-421;hsa-miR-590-5p;hsa-miR-629-3p 21 PRICKLE2 Sponge network -1.728 0.00016 -2.154 0 0.332
14

KCNQ1OT1

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-708-5p 10 FZD4 Sponge network -0.725 0.08874 -1.774 0 0.329
15

PCA3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-181a-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 20 CCND2 Sponge network -2.778 8.0E-5 -0.496 0.3 0.318
16

RFPL1S

 hsa-miR-144-3p;hsa-miR-148b-5p;hsa-miR-19b-1-5p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-338-3p;hsa-miR-3614-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p 10 CAMK2A Sponge network -0.223 0.70704 -0.131 0.82753 0.31
17

MEG3

 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-629-3p 16 FZD4 Sponge network -1.645 0.00049 -1.774 0 0.304
18

PLAC4

 hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p 11 NLK Sponge network -0.563 0.27163 0.087 0.60941 0.302
19 HCG18 hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p 11 NLK Sponge network -0.24 0.23472 0.087 0.60941 0.285
20

AGAP11

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-212-3p;hsa-miR-26b-3p;hsa-miR-320b 11 NFAT5 Sponge network -1.728 0.00016 -0.044 0.82158 0.278
21

PCA3

 hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-200c-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-369-3p;hsa-miR-590-3p;hsa-miR-93-3p;hsa-miR-944 11 PRKCA Sponge network -2.778 8.0E-5 -0.525 0.15685 0.278
22

PLAC4

 hsa-let-7a-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 10 FZD4 Sponge network -0.563 0.27163 -1.774 0 0.277
23 DGCR5 hsa-miR-107;hsa-miR-126-5p;hsa-miR-148a-5p;hsa-miR-2110;hsa-miR-30d-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-577;hsa-miR-592;hsa-miR-652-3p 10 CSNK1A1 Sponge network 1.383 0.01835 -0.125 0.51313 0.276
24

EMX2OS

 hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-500a-3p;hsa-miR-577;hsa-miR-92a-3p;hsa-miR-92b-3p 13 DAAM1 Sponge network -1.088 0.10042 -0.57 0.03626 0.274
25

RFPL1S

 hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-7-1-3p 10 PRICKLE2 Sponge network -0.223 0.70704 -2.154 0 0.273
26

CASC2

 hsa-let-7a-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 11 FZD4 Sponge network -0.561 0.05962 -1.774 0 0.271
27 FAM95B1 hsa-miR-185-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 10 FZD4 Sponge network -1.726 0.00466 -1.774 0 0.268
28

MEG3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-26b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-652-3p 12 NFAT5 Sponge network -1.645 0.00049 -0.044 0.82158 0.265
29

PCA3

 hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200c-3p;hsa-miR-330-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 11 PRKACB Sponge network -2.778 8.0E-5 -2.003 0 0.257
30

MEG3

 hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-577 11 DAAM1 Sponge network -1.645 0.00049 -0.57 0.03626 0.252

Quest ID: e6da37de254b1e4184776715d47dc192